The Bcl-2 protein family and its role in the development of neoplastic disease

Experimental Gerontology

Volumn 39, Issue 8, 2004, Pages 1125-1135

  Heiser, Dietmar ^a   Labi, Verena ^a   Erlacher, Miriam ^a   Villunger, Andreas ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Apoptosis; Bcl 2 family; BH3 only proteins; Tumorigenesis

Indexed keywords

BH3 PROTEIN; BIM PROTEIN; CASPASE 3; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN BCL X; PROTEIN BCL XL; PROTEIN BID; PROTEIN MCL 1; PROTEIN P44; PROTEIN P53;

AGING; APOPTOSIS; AUTOIMMUNITY; CALORIC RESTRICTION; CARCINOGENESIS; CELL AGING; CELL SURVIVAL; DNA DAMAGE; EMBRYO DEVELOPMENT; ENZYME BINDING; FIBROBLAST; HUMAN; LYMPHOCYTE; LYMPHOID HYPERPLASIA; NEOPLASM; NONHUMAN; ONCOGENE C MYC; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; PROTEIN FAMILY; SHORT SURVEY; SOMATIC CELL; STATISTICAL SIGNIFICANCE; TUMOR GROWTH;

MAMMALIA; METAZOA;

EID: 3543123595     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2004.04.011     Document Type: Review

References (152)

1. Acton D., Domen J., Jacobs H., Vlaar M., Korsmeyer S., Berns A. Collaboration of PIM-1 and BCL-2 in lymphomagenesis. Current Topics in Microbiology and Immunology. 182:1992;293-298
2. Akiyama T., Bouillet P., Miyazaki T., Kadono Y., Chikuda H., Chung U.I., Fukuda A., Hikita A., Seto H., Okada T., et al. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. Embo Journal. 22:2003;6653-6664
3. H on chromosome 14 and near a transcriptional unit on 18. Cell. 41:1985;899-906
4. Barr P.J., Tomei L.D. Apoptosis and its role in human disease. Biotechnology. 12:1994;487-493
5. Bischof O., Kim S.H., Irving J., Beresten S., Ellis N.A., Campisi J. Regulation and localization of the Bloom syndrome protein in response to DNA damage. Journal of Cell Biology. 153:2001;367-380
6. Boatright K.M., Salvesen G.S. Caspase activation. Biochemical Society Symposium. 2003;233-242
7. Boatright K.M., Renatus M., Scott F.L., Sperandio S., Shin H., Pedersen I.M., Ricci J.E., Edris W.A., Sutherlin D.P., Green D.R., Salvesen G.S. A unified model for apical caspase activation. Molecular Cell. 11:2003;529-541
8. Boise L.H., Gonzalez-Garcia M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nuñez G., Thompson C.B. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:1993;597-608
9. Boldin M.P., Varfolomeev E.E., Pancer Z., Mett I.L., Camonis J.H., Wallach D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. Journal of Biological Chemistry. 270:1995;7795-7798
10. Bouillet P., Metcalf D., Huang D.C.S., Tarlinton D.M., Kay T.W.H., Köntgen F., Adams J.M., Strasser A. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science. 286:1999;1735-1738
11. Bouillet P., Purton J.F., Godfrey D.I., Zhang L.-C., Coultas L., Puthalakath H., Pellegrini M., Cory S., Adams J.M., Strasser A. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature. 415:2002;922-926
12. Boyd J.M., Gallo G.J., Elangovan B., Houghton A.B., Malstrom S., Avery B.J., Ebb R.G., Subramanian T., Chittenden T., Lutz R.J., Chinnadurai G. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene. 11:1995;1921-1928
13. Chen F., Hersh B.M., Conradt B., Zhou Z., Riemer D., Gruenbaum Y., Horvitz H.R. Translocation of C. elegans CED-4 to nuclear membranes during programmed cell death. Science. 287:2000;1485-1489
14. Chinnaiyan A.M., O'Rourke K., Tewari M., Dixit V.M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81:1995;505-512
15. Chinnaiyan A.M., O'Rourke K., Lane B.R., Dixit V.M. Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science. 275:1997;1122-1126
16. Chipuk J.E., Maurer U., Green D.R., Schuler M. Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription. Cancer Cell. 4:2003;371-381
17. Chittenden T., Harrington E.A., O'Connor R., Flemington C., Lutz R.J., Evan G.I., Guild B.C. Induction of apoptosis by the Bcl-2 homologue Bak. Nature. 374:1995;733-736
18. Choi S.S., Park I.C., Yun J.W., Sung Y.C., Hong S.I., Shin H.S. A novel bcl-2 related gene, bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene. 11:1995;1693-1698
19. Coultas L., Pellegrini M., Visvader J.E., Lindeman G.J., Chen L., Adams J.M., Huang D.C., Strasser A. Bfk: a novel weakly proapoptotic member of the Bcl-2 protein family with a BH3 and a BH2 region. Cell Death and Differentiation. 10:2003;185-192
20. Courtois S., Verhaegh G., North S., Luciani M.G., Lassus P., Hibner U., Oren M., Hainaut P. DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53. Oncogene. 21:2002;6722-6728
21. de Boer J., Andressoo J.O., de Wit J., Huijmans J., Beems R.B., van Steeg H., Weeda G., van der Horst G.T., van Leeuwen W., Themmen A.P., et al. Premature aging in mice deficient in DNA repair and transcription. Science. 296:2002;1276-1279
22. Dijkers P.F., Medemadagger R.H., Lammers J.J., Koenderman L., Coffer P.J. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Current Biology. 10:2000;1201-1204
23. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A.J., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but are susceptible to spontaneous tumours. Nature. 356:1992;215-221
24. Donepudi M., Mac Sweeney A., Briand C., Grutter M.G. Insights into the regulatory mechanism for caspase-8 activation. Molecular Cell. 11:2003;543-549
25. Du C., Fang M., Li Y., Li L., Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell. 102:2000;33-42
26. Egle A., Harris A.W., Bath M.L., O'Reilly L., Cory S. VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. 2003
27. Farrow S.N., White J.H.M., Martinou I., Raven T., Pun K.-T., Grinham C.J., Martinou J.-C., Brown R. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature. 374:1995;731-733
28. Garcia-Cao I., Garcia-Cao M., Martin-Caballero J., Criado L.M., Klatt P., Flores J.M., Weill J.C., Blasco M.A., Serrano M. "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally. Embo Journal. 21:2002;6225-6235
29. Gibson L., Holmgreen S., Huang D.C.S., Bernard O., Copeland N.G., Jenkins N.A., Sutherland G.R., Baker E., Adams J.M., Cory S. bcl-w, a novel member of the bcl-2 family, promotes cell survival. Oncogene. 13:1996;665-675
30. Gray M.D., Shen J.C., Kamath-Loeb A.S., Blank A., Sopher B.L., Martin G.M., Oshima J., Loeb L.A. The Werner syndrome protein is a DNA helicase. Nature Genetics. 17:1997;100-103
31. Guo B., Godzik A., Reed J.C. Bcl-G, a novel pro-apoptotic member of the Bcl-2 family. Journal of Biological Chemistry. 276:2001;2780-2785
32. Han J., Sabbatini P., White E. Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K. Molecular and Cellular Biology. 16:1996;5857-5864
33. Han J., Flemington C., Houghton A.B., Gu Z., Zambetti G.P., Lutz R.J., Zhu L., Chittenden T. Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proceedings of the National Academy of Sciences of the USA. 98:2001;11318-11323
34. Harris C.A., Johnson E.M. Jr. BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons. Journal of Biological Chemistry. 276:2001;37754-37760
35. L. Journal of Cell Biology. 149:2000;623-634
36. Hegde R., Srinivasula S.M., Zhang Z., Wassell R., Mukattash R., Cilenti L., DuBois G., Lazebnik Y., Zervos A.S., Fernandes-Alnemri T., Alnemri E.S. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. Journal of Biological Chemistry. 277:2002;432-438
37. Hengartner M.O. CED-4 is a stranger no more. Nature. 388:1997;714-715
38. Hengartner M.O., Horvitz H.R. Programmed cell death in Caenorhabditis elegans. Current Opinion in Genetics and Development. 4:1994;581-586
39. Holcik M., Korneluk R.G. XIAP, the guardian angel. Nature Reviews. Molecular Cell Biology. 2:2001;550-556
40. Hsu H., Xiong J., Goeddel D.V. The TNF receptor 1-associated protein TRADD signals cell death and NF-kB activation. Cell. 81:1995;495-504
41. Hsu H., Shu H.-B., Pan M.-G., Goeddel D.V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 84:1996;299-308
42. Hsu S.Y., Kaipia A., McGee E., Lomeli M., Hsueh A.J.W. Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members. Proceedings of the National Academy of Sciences of the United States of America. 94:1997;12401-12406
43. Imaizumi K., Tsuda M., Imai Y., Wanaka A., Takagi T., Tohyama M. Molecular cloning of a novel polypeptide, DP5, induced during programmed neuronal death. Journal of Biological Chemistry. 272:1997;18842-18848
44. Inohara N., Núñez G. Genes with homology to mammalian apoptosis regulators identified in zebrafish [letter]. Cell Death and Differentiation. 7:2000;509-510
45. L. EMBO Journal. 16:1997;1686-1694
46. Itoh N., Nagata S. A novel protein domain required for apoptosis. Journal of Biological Chemistry. 268:1993;10932-10937
47. Jacks T., Remington L., Williams B.O., Schmitt E.M., Halachmi S., Bronson R.T., Weinberg R.A. Tumor spectrum analysis in p53-mutant mice. Current Biology. 4:1994;1-7
48. Jäger R., Herzer U., Schenkel J., Weiher H. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice. Oncogene. 15:1997;1787-1795
49. Jeffers J.R., Parganas E., Lee Y., Yang C., Wang J., Brennan J., MacLean K.H., Han J., Chittenden T., Ihle J.N. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell. 4:2003;321-328
50. Kataoka T., Holler N., Micheau O., Martinon F., Tinel A., Hofmann K., Tschopp J. Bcl-rambo, a novel Bcl-2 homologue that induces apoptosis via its unique C-terminal extension. Journal of Biological Chemistry. 276:2001;19548-19554
51. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer. 26:1972;239-257
52. Kiefer M.C., Brauer M.J., Powers V.C., Wu J.J., Umansky S.R., Tomei L.D., Barr P.J. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature. 374:1995;736-739
53. Kischkel F.C., Lawrence D.A., Chuntharapai A., Schow P., Kim K.J., Ashkenazi A. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity. 12:2000;611-620
54. Kogan S.C., Brown D.E., Shultz D.B., Truong B.T., Lallemand-Breitenbach V., Guillemin M.C., Lagasse E., Weissman I.L., Bishop J.M. BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor a chimeric protein (PMLRARa) to block neutrophil differentiation and initiate acute leukemia. Journal of Experimental Medicine. 193:2001;531-543
55. Kozopas K.M., Yang T., Buchan H.L., Zhou P., Craig R.W. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to bcl-2. Proceedings of the National Academy of Sciences of the United States of America. 90:1993;3516-3520
56. Letai A., Bassik M., Walensky L., Sorcinelli M., Weiler S., Korsmeyer S. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell. 2:2002;183
57. Li H., Zhu H., Xu C.-J., Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:1998;491-501
58. Li L.Y., Luo X., Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature. 412:2001;95-99
59. Lindsten T., Ross A.J., King A., Zong W., Rathmell J.C., Shiels H.A., Ulrich E., Waymire K.G., Mahar P., Frauwirth K., et al. The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues. Molecular Cell. 6:2000;1389-1399
60. Liston P., Fong W.G., Korneluk R.G. The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene. 22:2003;8568-8580
61. Liu G., Parant J.M., Lang G., Chau P., Chavez-Reyes A., El-Naggar A.K., Multani A., Chang S., Lozano G. Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Nature Genetics. 36:2004;63-68
62. Lorenzo H.K., Susin S.A., Penninger J., Kroemer G. Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death [In Process Citation]. Cell Death and Differentiation. 6:1999;516-524
63. Luo X., Budlhardjo I., Zou H., Slaughter C., Wang X. Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 94:1998;481-490
64. Maier B., Gluba W., Bernier B., Turner T., Mohammad K., Guise T., Sutherland A., Thorner M., Scrable H. Modulation of mammalian life span by the short isoform of p53. Genes and Development. 18:2004;306-319
65. Marsden V.S., O'Connor L., O'Reilly L.A., Silke J., Metcalf D., Ekert P.G., Huang D.C., Cecconi F., Kuida K., Tomaselli K.J. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature. 419:2002;634-637
66. Martins L.M., Iaccarino I., Tenev T., Gschmeissner S., Totty N.F., Lemoine N.R., Savopoulos J., Gray C.W., Creasy C.L., Dingwall C., Downward J. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. Journal of Biological Chemistry. 277:2002;439-444
67. McDonnell T.J., Korsmeyer S.J. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature. 349:1991;254-256
68. Mihara M., Erster S., Zaika A., Petrenko O., Chittenden T., Pancoska P., Moll U.M. p53 has a direct apoptogenic role at the mitochondria. Molecular Cell. 11:2003;577-590
69. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:1995;293-299
70. Montpetit A., Boily G., Sinnett D. A detailed transcriptional map of the chromosome 12p12 tumour suppressor locus. European Journal of Human Genetics. 10:2002;62-71
71. Moriishi K., Huang D.C.S., Cory S., Adams J.M. Bcl-2 family members do not inhibit apoptosis by binding the caspase-activator Apaf-1. Proceedings of the National Academy of Sciences of the United States of America. 96:1999;9683-9688
72. Moroni M.C., Hickman E.S., Denchi E.L., Caprara G., Colli E., Cecconi F., Müller H., Helin K. Apaf-1 is a transcriptional target for E2F and p53. Nature Cell Biology. 3:2001;552-558
73. Muzio M., Chinnaiyan A.M., Kischkel F.C., O'Rourke K., Shevchenko A., Ni J., Scaffidi C., Bretz J.D., Zhang M., Gentz R. FLICE, a novel FADD homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex. Cell. 85:1996;817-827
74. Nagata S. Fas ligand and immune evasion. Nature Medicine. 2:1996;1306-1307
75. Nagata S., Golstein P. The Fas death factor. Science. 267:1995;1449-1456
76. Naik P., Karrim J., Hanahan D. The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes and Development. 10:1996;2105-2116
77. Nakano K., Vousden K.H. PUMA, a novel proapoptotic gene, is induced by p53. Molecular Cell. 7:2001;683-694
78. Newton K., Harris A.W., Bath M.L., Smith K.G.C., Strasser A. A dominant interfering mutant of FADD/Mort1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO Journal. 17:1998;706-718
79. Nicholson D.W. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death and Differentiation. 6:1999;1028-1042
80. Nieborowska-Skorska M., Hoser G., Kossev P., Wasik M.A., Skorski T. Complementary functions of the antiapoptotic protein A1 and serine/threonine kinase pim-1 in the BCR/ABL-mediated leukemogenesis. Blood. 99:2002;4531-4539
81. O'Connor L., Strasser A., O'Reilly L.A., Hausmann G., Adams J.M., Cory S., Huang D.C.S. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO Journal. 17:1998;384-395
82. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., Tokino T., Taniguchi T., Tanaka N. Noxa, a BH3-only member of the bcl-2 family and candidate mediator of p53-induced apoptosis. Science. 288:2000;1053-1058
83. Oda K., Arakawa H., Tanaka T., Matsuda K., Tanikawa C., Mori T., Nishimori H., Tamai K., Tokino T., Nakamura Y., Taya Y. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell. 102:2000;849-862
84. Oltvai Z.N., Korsmeyer S.J. Checkpoints of dueling dimers foil death wishes. Cell. 79:1994;189-192
85. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog. Bax, that accelerates programmed cell death. Cell. 74:1993;609-619
86. O'Reilly L.A., Strasser A. Apoptosis and autoimmune disease. Inflammation Research. 48:1999;5-21
87. Ottonello L., Tortolina G., Amelotti M., Dallegri F. Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes. Journal of Immunology. 162:1999;3601-3606
88. L by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Genes and Development. 12:1998;2475-2487
89. L, and Apaf-1 form a ternary complex. Journal of Biological Chemistry. 273:1998;5841-5845
90. Pelengaris S., Khan M., Evan G.I. Suppression of Myc-induced apoptosis in b cells exposes multiple oncogenic properties of myc and triggers carcinogenic progression. Cell. 109:2002;321-334
91. Peschon J.J., Torrance D.S., Stocking K.L., Glaccum M.B., Otten C., Willis C.R., Charrier K., Morrissey P.J., Ware C.B., Mohler K.M. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. Journal of Immunology. 160:1998;943-952
92. Pinkoski M.J., Green D.R. Lymphocyte apoptosis: refining the paths to perdition. Current Opinion in Hematology. 9:2002;43-49
93. Puthalakath H., Huang D.C.S., O'Reilly L.A., King S.M., Strasser A. The pro-apoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Molecular Cell. 3:1999;287-296
94. Puthalakath H., Villunger A., O'Reilly L.A., Beaumont J.G., Coultas L., Cheney R.E., Huang D.C.S., Strasser A. Bmf: a pro-apoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science. 293:2001;1829-1832
95. Rampino N., Yamamoto H., Ionov Y., Li Y., Sawai H., Reed J.C., Perucho M. Somatic frameshift mutations in the bax gene in colon cancers of the microsatellite mutator phenotype. Science. 275:1997;967-969
96. Salmena L., Lemmers B., Hakem A., Matysiak-Zablocki E., Murakami K., Au P.Y., Berry D.M., Tamblyn L., Shehabeldin A., Migon E., et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes and Dev. 17:2003;883-895
97. Salvesen G.S., Dixit V.M. Caspase activation: the induced-proximity model. Proceedings of the National Academy of Sciences of the United States of America. 96:1999;10964-10967
98. Sax J.K., Fei P., Murphy M.E., Bernhard E., Korsmeyer S.J., El-Deiry W.S. BID regulation by p53 contributes to chemosensitivity. Nature Cell Biology. 4:2002;842-849
99. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., Debatin K.-M., Krammer P.H., Peter M.E. Two CD95 (APO-1/Fas) signaling pathways. EMBO Journal. 17:1998;1675-1687
100. Schmitt C.A., Fridman J.S., Yang M., Baranov E., Hoffman R.M., Lowe S.W. Dissecting p53 tumor suppressor functions in vivo. Cancer Cell. 1:2002;289-298
101. Schneider P., Holler N., Bodmer J.L., Hahne M., Frei K., Fontana A., Tschopp J. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. Journal of Experimental Medicine. 187:1998;1205-1213
102. Schumacher B., Hofmann K., Boulton S., Gartner A. The C. elegans homolog of the p53 tumor suppressor is required for DNA damage-induced apoptosis. Current Biology. 11:2001;1722-1727
103. Seino K., Iwabuchi K., Kayagaki N., Miyata R., Nagaoka I., Matsuzawa A., Fukao K., Yagita H., Okumura K. Chemotactic activity of soluble Fas ligand against phagocytes. Journal of Immunology. 161:1998;4484-4488
104. Shibata M.A., Liu M.L., Knudson M.C., Shibata E., Yoshidome K., Bandey T., Korsmeyer S.J., Green J.E. Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage. EMBO Journal. 18:1999;2692-2701
105. Shibue T., Takeda K., Oda E., Tanaka H., Murasawa H., Takaoka A., Morishita Y., Akira S., Taniguchi T., Tanaka N. Integral role of Noxa in p53-mediated apoptotic response. Genes and Development. 17:2003;2233-2238
106. Soengas M.S., Alarcón R.M., Yoshida H., Giaccia A.J., Hakem R., Mak T.W., Lowe S.W. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science. 284:1999;156-159
107. Sprick M.R., Weigand M.A., Rieser E., Rauch C.T., Juo P., Blenis J., Krammer P.H., Walczak H. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity. 12:2000;599-609
108. Stambolic V., MacPherson D., Sas D., Lin Y., Snow B., Jang Y., Benchimol S., Mak T.W. Regulation of PTEN transcription by p53. Molecular Cell. 8:2001;317-325
109. Strasser A., Newton K. FADD/MORT1, a signal transducer that can promote cell death or cell growth. International Journal of Biochemistry and Cell Biology. 31:1999;533-537
110. Strasser A., Harris A.W., Bath M.L., Cory S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature. 348:1990;331-333
111. Strasser A., Whittingham S., Vaux D.L., Bath M.L., Adams J.M., Cory S., Harris A.W. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proceedings of the National Academy of Sciences of the USA. 88:1991;8661-8665
112. Strasser A., Harris A.W., Cory S. Lavin M., Watters D. The bcl-2 oncogene regulates lymphocyte survival and potentiates lymphomagenesis. 1993;167-177 Harwood Academic Publishers, Switzerland
113. Strasser A., Harris A.W., Cory S. Em-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells. Oncogene. 8:1993;1-9
114. Strasser A., Harris A.W., Jacks T., Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell. 79:1994;329-339
115. Strasser A., Harris A.W., Huang D.C.S., Krammer P.H., Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO Journal. 14:1995;6136-6147
116. Strasser A., O'Connor L., Dixit V.M. Apoptosis signaling. Annual Review of Biochemistry. 69:2000;217-245
117. Suh Y., Lee K.A., Kim W.H., Han B.G., Vijg J., Park S.C. Aging alters the apoptotic response to genotoxic stress. Nature Medicine. 8:2002;3-4
118. Suzuki M., Youle R.J., Tjandra N. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell. 103:2000;645-654
119. Suzuki Y., Imai Y., Nakayama H., Takahashi K., Takio K., Takahashi R. A serine protease HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Molecular Cell. 8:2001;613-621
120. Tanaka M., Itai T., Adachi M., Nagata S. Downregulation of Fas ligand by shedding. Nature Medicine. 4:1998;31-36
121. Tartaglia L.A., Ayres T.M., Wong G.H.W., Goeddel D.V. A novel domain within the 55 kd TNF receptor signals cell death. Cell. 74:1993;845-853
122. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462
123. Traver D., Akashi K., Weissman I.L., Lagasse E. Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. Immunity. 9:1998;47-57
124. Tsujimoto Y., Finger L.R., Yunis J., Nowell P.C., Croce C.M. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science. 226:1984;1097-1099
125. Tyner S.D., Venkatachalam S., Choi J., Jones S., Ghebranious N., Igelmann H., Lu X., Soron G., Cooper B., Brayton C., et al. p53 mutant mice that display early ageing-associated phenotypes. Nature. 415:2002;45-53
126. van Loo G., van Gurp M., Depuydt B., Srinivasula S.M., Rodriguez I., Alnemri E.S., Gevaert K., Vandekerckhove J., Declercq W., Vandenabeele P. The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity. Cell Death and Differentiation. 9:2002;20-26
127. Vaux D.L., Cory S., Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:1988;440-442
128. Verhagen A.M., Ekert P.G., Pakusch M., Silke J., Connolly L.M., Reid G.E., Moritz R.L., Simpson R.J., Vaux D.L. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing inhibitor of apoptosis (IAP) proteins. Cell. 102:2000;43-53
129. Verhagen A.M., Silke J., Ekert P.G., Pakusch M., Kaufmann H., Connolly L.M., Day C.L., Tikoo A., Burke R., Wrobel C. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. Journal of Biological Chemistry. 277:2002;445-454
130. Villunger A., O'Reilly L.A., Holler N., Adams J.M., Strasser A. Bcl-2, G-CSF and p38 MAPK: regulators of distinct cell death and survival pathways in granulocytes Fas ligand. Journal of Experimental Medicine. 192:2000;647-657
131. Villunger A., Michalak E.M., Coultas L., Mullauer F., Bock G., Ausserlechner M.J., Adams J.M., Strasser A. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science. 302:2003;1036-1038
132. Vousden K.H., Lu X. Live or let die: the cell's response to p53. Nature Reviews. Cancer. 2:2002;594-604
133. Walker L.S., Abbas A.K. The enemy within: keeping self-reactive T cells at bay in the periphery. Nature Reviews. Immunology. 2:2002;11-19
134. Wallach D., Kovalenko A.V., Varfolomeev E.E., Boldin M.P. Death-inducing functions of ligands of the tumor necrosis factor family: a Sanhedrin verdict. Current Opinion in Immunology. 10:1998;279-288
135. Wang K., Yin X.-M., Chao D.T., Milliman C.L., Korsmeyer S.J. BID: a novel BH3 domain-only death agonist. Genes and Development. 10:1996;2859-2869
136. Warner H.R., Fernandes G., Wang E. A unifying hypothesis to explain the retardation of aging and tumorigenesis by caloric restriction. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 50:1995;B107-B109
137. Wei M.C., Zong W.X., Cheng E.H., Lindsten T., Panoutsakopoulou V., Ross A.J., Roth K.A., MacGregor G.R., Thompson C.B., Korsmeyer S.J. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 292:2001;727-730
138. Woo M., Hakem R., Furlonger C., Hakem A., Duncan G.S., Sasaki T., Bouchard D., Lu L., Wu G.E., Paige C.J., Mak T.W. Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity. Nature Immunology. 4:2003;1016-1022
139. Wu G.S., Burns T.F., McDonald E.R. III, Jiang W., Meng R., Krantz I.D., Kao G., Gan D.-D., Zhou J.-Y., Muschel R., et al. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nature Genetics. 17:1997;141-143
140. Wyllie A.H., Kerr J.F.R., Currie A.R. Cell death: the significance of apoptosis. International Review of Cytology. 68:1980;251-306
141. L and Bcl-2, displaces Bax and promotes cell death. Cell. 80:1995;285-291
142. Yannone S.M., Roy S., Chan D.W., Murphy M.B., Huang S., Campisi J., Chen D.J. Werner syndrome protein is regulated and phosphorylated by DNA-dependent protein kinase. Journal of Biological Chemistry. 276:2001;38242-38248
143. Yin C.Y., Knudson C.M., Korsmeyer S.J., Van Dyke T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature. 385:1997;637-640
144. Yin X.-M., Wang K., Gross A., Zhao Y., Zinkel S., Klocke B., Roth K.A., Korsmeyer S.J. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature. 400:1999;886-891
145. Yin Y., Stephen C.W., Luciani M.G., Fahraeus R. p53 stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products. Nature Cell Biology. 4:2002;462-467
146. Yu J., Zhang L., Hwang P.M., Kinzler K.W., Vogelstein B. PUMA induces the rapid apoptosis of colorectal cancer cells. Molecular Cell. 7:2001;673-682
147. Yu J., Wang Z., Kinzler K.W., Vogelstein B., Zhang L. PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 100:2003;1931-1936
148. L. Cell. 87:1996;619-628
149. Zhang J., Cado D., Chen A., Kabra N.H., Winoto A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature. 392:1998;296-300
150. Zhou P., Levy N.B., Xie H., Qian L., Lee C.Y., Gascoyne R.D., Craig R.W. MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. Blood. 97:2001;3902-3909
151. Zinkel S.S., Ong C.C., Ferguson D.O., Iwasaki H., Akashi K., Bronson R.T., Kutok J.L., Alt F.W., Korsmeyer S.J. Proapoptotic BID is required for myeloid homeostasis and tumor suppression. Genes and Development. 17:2003;229-239
152. Zong W.X., Lindsten T., Ross A.J., MacGregor G.R., Thompson C.B. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes and Development. 15:2001;1481-1486